ResearcherUniversity of MichiganNo recent work listed

Yajing Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1311-1220; OpenAlex author ID A5100629041. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2020: 1 paper

Papers 1

UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer. Co-author DOI 10.1016/j.tranon.2020.100834 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mats E. Ljungman · 1 shared paper, 2020 · strength 0.09
- Paper UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cance… DOI 10.1016/j.tranon.2020.100834 ↗
Theodore Steven Lawrence · 1 shared paper, 2020 · strength 0.09
- Paper UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cance… DOI 10.1016/j.tranon.2020.100834 ↗
Alnawaz Rehemtulla · 1 shared paper, 2020 · strength 0.09
- Paper UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cance… DOI 10.1016/j.tranon.2020.100834 ↗
Meredith Ann Morgan · 1 shared paper, 2020 · strength 0.09
- Paper UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cance… DOI 10.1016/j.tranon.2020.100834 ↗
Carl G. Engelke · 1 shared paper, 2020 · strength 0.09
- Paper UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cance… DOI 10.1016/j.tranon.2020.100834 ↗
Nouri Neamati · 1 shared paper, 2020 · strength 0.09
- Paper UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cance… DOI 10.1016/j.tranon.2020.100834 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.